Harel Insurance Investments & Financial Services Ltd. continued to hold its position in Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 780,000 shares of the biopharmaceutical company’s stock at the end of the second quarter. Harel Insurance Investments & Financial Services Ltd.’s holdings in Navidea Biopharmaceuticals were worth $398,000 at the end of the most recent quarter.

Separately, HighTower Advisors LLC increased its position in Navidea Biopharmaceuticals by 7.2% in the first quarter. HighTower Advisors LLC now owns 177,966 shares of the biopharmaceutical company’s stock worth $104,000 after buying an additional 11,900 shares in the last quarter.

Navidea Biopharmaceuticals Inc (NAVB) opened at 0.3956 on Friday. Navidea Biopharmaceuticals Inc has a 1-year low of $0.26 and a 1-year high of $1.16. The company has a market capitalization of $63.96 million and a P/E ratio of 0.8276. The firm has a 50-day moving average price of $0.47 and a 200-day moving average price of $0.51.

Navidea Biopharmaceuticals (NYSEMKT:NAVB) last issued its quarterly earnings data on Tuesday, August 8th. The biopharmaceutical company reported ($0.02) EPS for the quarter. The business had revenue of $0.61 million during the quarter. On average, analysts forecast that Navidea Biopharmaceuticals Inc will post ($0.08) EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/08/11/navidea-biopharmaceuticals-inc-nysemktnavb-stake-maintained-by-harel-insurance-investments-financial-services-ltd.html.

Navidea Biopharmaceuticals Company Profile

Navidea Biopharmaceuticals, Inc is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple precision-targeted products based on the Manocept platform to help identify the sites and pathways of undetected disease.

Want to see what other hedge funds are holding NAVB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB).

Institutional Ownership by Quarter for Navidea Biopharmaceuticals (NYSEMKT:NAVB)

Receive News & Ratings for Navidea Biopharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.